Probing Molecular Packing of Drug Substances in Nanometer Domains in Pharmaceutical Formulations Using 19F Magic Angle Spinning NMR
Source abstract
Abstract
Structural details of molecular packing provide a fundamental understanding of the resulting material properties of pharmaceutical materials. For example, both the physical stability and dissolution rate of amorphous drugs are significantly enhanced by embedding into a polymeric network to form an amorphous solid dispersion. Despite the ubiquitous use of amorphous solid dispersions to formulate poorly water-soluble drugs, structural details elucidating the molecular mechanism of drug recrystallization remain elusive. In this study, solid-state NMR was used to quantitatively determine the size of the drug-rich domains in amorphous solid dispersions and determine the number of drug molecules within the polymer matrix by using 19 F centerband-only detection of exchange (CODEX). Such results provide the highest resolution of oligomeric packing of drug molecules in the nanometer domain in an amorphous dispersion and offer a valuable structural basis for how drug–drug interaction induces recrystallization in a confined polymer matrix.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced NMR Techniques and Applications · NMR spectroscopy and applications · Advanced MRI Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Analytical Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States
References (64)
Show source-provided references
1. 10.1016/j.ijpharm.2020.11956010.1016/j.ijpharm.2020.119560 ↗
2. 10.1016/j.apsb.2021.05.01410.1016/j.apsb.2021.05.014 ↗
3. 10.1016/j.ddtec.2011.10.00210.1016/j.ddtec.2011.10.002 ↗
4. 10.1002/jps.2207410.1002/jps.22074 ↗
5. 10.1002/jps.2335810.1002/jps.23358 ↗
6. 10.1021/mp500514610.1021/mp5005146 ↗
7. 10.1021/acs.molpharmaceut.6b0074010.1021/acs.molpharmaceut.6b00740 ↗
8. 10.1021/acs.molpharmaceut.8b0021910.1021/acs.molpharmaceut.8b00219 ↗
9. 10.1021/acs.molpharmaceut.6b0080310.1021/acs.molpharmaceut.6b00803 ↗
10. 10.1021/acs.molpharmaceut.9b0127210.1021/acs.molpharmaceut.9b01272 ↗
11. 10.1007/s11095-016-1969-210.1007/s11095-016-1969-2 ↗
12. 10.1021/acs.molpharmaceut.0c0059210.1021/acs.molpharmaceut.0c00592 ↗
13. 10.1016/j.jpba.2017.07.06610.1016/j.jpba.2017.07.066 ↗
14. 10.1016/j.ijpharm.2018.07.02910.1016/j.ijpharm.2018.07.029 ↗
15. 10.1021/acs.molpharmaceut.5b0092510.1021/acs.molpharmaceut.5b00925 ↗
16. 10.1016/j.trac.2020.11615210.1016/j.trac.2020.116152 ↗
17. 10.1007/s11095-017-2145-z10.1007/s11095-017-2145-z ↗
18. 10.1016/j.ijpharm.2018.11.06710.1016/j.ijpharm.2018.11.067 ↗
19. 10.1016/j.ijpharm.2018.07.02910.1016/j.ijpharm.2018.07.029 ↗
20. 10.1021/mp100205g10.1021/mp100205g ↗
21. 10.1021/mp400498n10.1021/mp400498n ↗
22. 10.1016/j.jddst.2019.01.01710.1016/j.jddst.2019.01.017 ↗
23. 10.1002/jps.2173810.1002/jps.21738 ↗
24. 10.1021/mp500829v10.1021/mp500829v ↗
25. 10.1021/acs.molpharmaceut.5b0070510.1021/acs.molpharmaceut.5b00705 ↗
26. 10.1021/acs.molpharmaceut.5b0033310.1021/acs.molpharmaceut.5b00333 ↗
27. 10.1021/mp500692a10.1021/mp500692a ↗
28. 10.1021/mp400495h10.1021/mp400495h ↗
29. 10.1021/acs.molpharmaceut.9b0030110.1021/acs.molpharmaceut.9b00301 ↗
30. 10.1016/j.jpba.2018.11.00110.1016/j.jpba.2018.11.001 ↗
31. 10.1002/mrc.126024090710.1002/mrc.1260240907 ↗
32. 10.1016/0378-5173(94)00208-M10.1016/0378-5173(94)00208-M ↗
33. 10.1016/S0939-6411(97)00118-510.1016/S0939-6411(97)00118-5 ↗
34. 10.1021/acs.molpharmaceut.9b0017410.1021/acs.molpharmaceut.9b00174 ↗
35. 10.1039/D0CP02049D10.1039/D0CP02049D ↗
36. 10.1021/acs.molpharmaceut.0c0026810.1021/acs.molpharmaceut.0c00268 ↗
37. 10.1063/1.497482910.1063/1.4974829 ↗
38. 10.1021/acs.jpcb.0c0213110.1021/acs.jpcb.0c02131 ↗
39. Schmidt-Rohr K. · Encyclopedia of Nuclear Magnetic Resonance · 2007 · 9 · 633
40. 10.1021/ja992022v10.1021/ja992022v ↗
41. 10.1021/ja060340610.1021/ja0603406 ↗
42. 10.1021/acs.molpharmaceut.9b0017410.1021/acs.molpharmaceut.9b00174 ↗
43. 10.1021/acs.jpcb.8b0031010.1021/acs.jpcb.8b00310 ↗
44. 10.1007/BF0226534910.1007/BF02265349 ↗
45. 10.1007/s11095-006-9086-210.1007/s11095-006-9086-2 ↗
46. 10.1016/j.jpba.2017.07.06610.1016/j.jpba.2017.07.066 ↗
47. 10.1002/actp.1993.01044010110.1002/actp.1993.010440101 ↗
48. 10.1021/jp073823k10.1021/jp073823k ↗
49. 10.1016/j.bpj.2016.09.04810.1016/j.bpj.2016.09.048 ↗
50. 10.1006/jmre.2001.235110.1006/jmre.2001.2351 ↗
51. 10.1016/j.jmb.2017.05.01510.1016/j.jmb.2017.05.015 ↗
52. 10.1016/j.bpj.2013.02.05410.1016/j.bpj.2013.02.054 ↗
53. 10.1021/bi900080d10.1021/bi900080d ↗
54. 10.1021/acs.analchem.1c0078410.1021/acs.analchem.1c00784 ↗
55. 10.1021/acs.analchem.1c0291710.1021/acs.analchem.1c02917 ↗
56. 10.1021/acs.analchem.9b0088410.1021/acs.analchem.9b00884 ↗
57. 10.1021/jacs.1c1205610.1021/jacs.1c12056 ↗
58. 10.1021/cg300370q10.1021/cg300370q ↗
59. 10.1021/acs.cgd.0c0031210.1021/acs.cgd.0c00312 ↗
60. 10.1002/anie.20190765210.1002/anie.201907652 ↗
61. 10.1002/cphc.20200051710.1002/cphc.202000517 ↗
62. 10.1021/ja00363a06010.1021/ja00363a060 ↗
63. 10.1021/ja00329a05210.1021/ja00329a052 ↗
64. 10.1016/j.jmr.2012.05.01910.1016/j.jmr.2012.05.019 ↗